Paula Rastrick

❓Why is it so difficult to openly discuss HRT side effects, hormonal sensitivity?

❓OR when prescribing hasn’t gone to plan - without being either attacked online or immediately labelled “anti-HRT”?

⚠️This is not an anti-treatment position - It is a patient safety question and that is absolutely valid.

🚩When medics speak on social media in absolutes and universal benefits (often without robust data ) conversations about sensitivity, adverse effects, or complexity are shut down.

An important question has to be asked:

⁉️How does medicine learn?

❓If patients’ lived experiences are dismissed rather than documented, where does safety data come from?

❓If complaints processes are absent or informal, how are mistakes identified and corrected?

❓If women are discouraged from speaking in clinics and in comments how is informed consent truly possible?

🚩This dynamic now extends across social media spaces, where women asking reasonable questions are often silenced if they don’t fit a simplified, idealised narrative of treatment working perfectly.

⚠️That is not evidence-based medicine.

🚩It is an echo chamber.

⚠️Medicine cannot progress if it only listens to compliant stories and excludes those who are hormonally sensitive, neurodivergent, traumatised, or complex.

✅Listening to difference is not a threat to care.

✅It is how medicine learns, improves, and protects patients.